analyst
AD
NASDAQ · ADPT
Adaptive Biotechnologies Corporation
Healthcare · Biotechnology
$29.43
Down-$0.14 (-0.47%)
Updated Sep 26, 2026, 9:25 PM
SID Score
6.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.45B
- P/E ratio
- -41.23
- Dividend yield
- 0.00%
- 52-week range
- $12.00 – $29.96
- Volume
- 1.69M
- Avg. volume
- 2.26M
Price performance
ADPT price history
1M range · 20 trading sessions · Daily adjusted prices
ADPT closed at $29.43 after 20 trading sessions, up 16.83% for the selected period.
- Last close
- $29.43
- Period change
- +16.83%
- Period low
- $24.20
- Period high
- $29.57
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 25, 2026 | $29.9599 | $29.9599 | $28.8766 | $29.43 | 1.69M |
| Sep 24, 2026 | $28.00 | $29.58 | $27.50 | $29.57 | 3.61M |
| Sep 23, 2026 | $27.74 | $28.35 | $27.60 | $27.89 | 1.08M |
| Sep 22, 2026 | $27.295 | $28.36 | $26.7329 | $28.06 | 4M |
| Sep 21, 2026 | $28.69 | $28.78 | $27.70 | $27.86 | 1.46M |
| Sep 18, 2026 | $28.55 | $28.68 | $27.91 | $28.61 | 2.99M |
| Sep 17, 2026 | $28.23 | $28.72 | $27.77 | $28.55 | 3.28M |
| Sep 16, 2026 | $27.09 | $28.72 | $27.03 | $27.67 | 5.03M |
| Sep 15, 2026 | $24.80 | $27.34 | $24.71 | $26.68 | 4.12M |
| Sep 14, 2026 | $24.26 | $24.878 | $23.965 | $24.78 | 1.73M |
| Sep 11, 2026 | $24.23 | $24.79 | $23.93 | $24.20 | 1.24M |
| Sep 10, 2026 | $23.81 | $24.65 | $23.53 | $24.23 | 1.07M |
| Sep 9, 2026 | $24.05 | $24.6799 | $23.89 | $24.42 | 1.11M |
| Sep 8, 2026 | $23.98 | $24.60 | $23.62 | $24.34 | 1.36M |
| Sep 4, 2026 | $24.06 | $24.40 | $23.94 | $24.28 | 1.4M |
| Sep 3, 2026 | $25.18 | $25.36 | $23.84 | $24.57 | 2.16M |
| Sep 2, 2026 | $24.40 | $25.23 | $24.185 | $24.66 | 1.62M |
| Sep 1, 2026 | $24.91 | $25.11 | $24.20 | $24.34 | 1.62M |
| Aug 31, 2026 | $24.61 | $25.02 | $23.865 | $24.92 | 2.24M |
| Aug 28, 2026 | $26.54 | $26.58 | $25.13 | $25.19 | 1.51M |
Latest ADPT news
The latest Smart Investors Daily articles mentioning ADPT.
Stock researchResearch & News · Analysis
Loading stock research…